Explore the vast range of titles available.

The short form of the leptin receptor (LeptRa) plays a key role in the transport of leptin to the central nervous system (CNS). Here, MTS-leptin and recombinant ovine (ro) leptin-mediated expression of LeptRa and VEGFA and VEGFR2 concentration in selected hypothalamic nuclei, choroid plexus (ChP), and anterior pituitary (AP) were analyzed considering the photoperiod and acute-fasting (experiment 1), and nutritional status (experiment 2) of ewes. In experiment 1, 60 sheep were fed normally or fasted for 72 h and received one injection of saline, MTS-leptin, or roleptin 1 h prior to euthanasia. LeptRa mRNA transcript levels and VEGF system protein concentrations were detected in the ARC, ChP predominantly in the SD, and AP for the LD without detection of LeptRa in the POA and VMH/DMH. In experiment 2, an altered diet for 5 months created lean or fat sheep. Twenty sheep were divided into four groups: the lean and fat groups were given saline, while the lean-R and fat-R groups received resistin 1 h prior to euthanasia. Changes in adiposity influenced the lowering effect of resistin on the expression of LeptRa and VEGF system protein concentrations. Overall, both photoperiodic and nutritional signals influence the effects of MTS-leptin/roleptin and resistin-mediated leptin transport to the CNS via LeptRa. Resistin seems to be another adipokine involved in the adaptive/pathological phenomenon of leptin resistance in sheep.

Both long-term undernutrition and overnutrition disturb metabolic balance, which is mediated partially by the action of two adipokines, leptin and resistin (RSTN). In this study, we manipulated the diet of ewes to produce either a thin (lean) or fat (fat) body condition and investigated how RSTN affects endocrine and metabolic status under different leptin concentrations. Twenty ewes were distributed into four groups (n = 5): the lean and fat groups were administered with saline (Lean and Fat), while the Lean-R (Lean-Resistin treated) and Fat-R (Fat-Resistin treated) groups received recombinant bovine resistin. Plasma was assayed for LH, FSH, PRL, RSTN, leptin, GH, glucose, insulin, total cholesterol, nonesterified fatty acid (NEFA), high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and triglycerides. Expression levels of a suppressor of cytokine signaling (SOCS-3) and the long form of the leptin receptor (LRb) were determined in selected brain regions, such as the anterior pituitary, hypothalamic arcuate nucleus, preoptic area and ventro- and dorsomedial nuclei. The results indicate long-term alterations in body weight affect RSTN-mediated effects on metabolic and reproductive hormones concentrations and the expression of leptin signaling components: LRb and SOCS-3. This may be an adaptive mechanism to long-term changes in adiposity during the state of long-day leptin resistance.

The effects of hyperleptinemia and leptin resistance during gestation are unclear. Leptin, an important neuroendocrine regulator, has anorexic effects, but its interactions with other metabolic hormones during pregnancy are unclear. We examined potential roles of leptin in regulating prolactin (PRL), GH, and melatonin plasma concentrations during pregnancy in Polish Longwool ewes. Twelve estrus-synchronized ewes carrying twins after mating were randomly assigned to receive i.v. injections of saline or recombinant ovine leptin (2.5 or 5.0 µg/kg BW). Blood samples were collected (15-min intervals over 4 h) immediately before the first injection at dusk and kept under red light. Treatments were repeated at 2-wk intervals, starting before mating and continuing from days 30 to 135 of gestation. Concentrations of plasma PRL, GH, and melatonin were determined using a validated RIA. The effects of leptin on hormone plasma concentrations varied depending on pregnancy stage and leptin dose. PRL plasma concentrations were affected at most stages of pregnancy and before gestation. In non-, very early- (day 30), and late- (day 120 and 135) pregnant ewes, exogenous leptin stimulated PRL (P < 0.001) plasma concentrations, while during the second month of gestation, it decreased PRL concentrations (P < 0.01). Leptin affected GH plasma concentrations (P < 0.05) only during the first 2 mo of pregnancy, with no effects during the second part of gestation or before pregnancy. In early-pregnant ewes (day 30 and 45), leptin decreased melatonin plasma concentrations (P < 0.05), but at day 60, leptin stimulated melatonin plasma concentrations at low (P < 0.01) and high doses (P < 0.05), with no effects in ewes after 105 d of gestation. These data indicate specific pregnancy-induced endocrine adaptations to changes in energy homeostasis, supporting the hypothesis that leptin affects PRL, GH, and melatonin release during gestation.

This study examined how leptin affects growth hormone (GH) release and investigated the effects of leptin, GH, and day length on the suppressor of cytokine signaling-3 (SOCS-3) mRNA levels in the adenohypophyses of sheep. The study consisted of two experiments. The first experiment was conducted during long (LD) and short (SD) days. Within-season and replicate sheep were centrally infused with Ringer-Locke buffer or leptin three times at 60-min intervals at the beginning of experiments. The second experiment involved adenohypophyses collected from sheep that were euthanized in May or November. Pituitary explants were treated with medium alone (Control) or medium with leptin or GH at different concentrations and incubated for various times. The results of the first experiment indicated GH concentrations were seasonally dependent and that leptin had no effect on GH secretion. The results of the second experiment indicated a stronger influence of leptin on the expression of SOCS-3 during the SD season than the LD season. During SDs, significant effects of both GH doses on SOCS-3 expression were observed. These results indicate a strong association between leptin, GH, and SOCS-3, which may explain the disruption of SOCS-3 leptin and GH signaling and the dominant effect of photoperiod on the above relationships.

The short form of the leptin receptor (LRa) plays a key role in the transport of leptin to the central nervous system (CNS). Here, the resistin (RSTN)-mediated expression of LRa in the preoptic area (POA), ventromedial and dorsomedial nuclei (VMH/DMH),arcuate nucleus (ARC) and the anterior pituitary gland (AP)was analyzed considering the photoperiodic (experiment 1) and nutritional status (experiment 2) of ewes. In experiment 1, 30 sheep were fed normally and received one injection of saline or two doses of RSTN one hour prior to euthanasia. RSTN increased LRa expression mainly in the ARC and AP during long days (LD) and only in the AP during short days (SD). In experiment 2, an altered diet for 5 months created lean or fat sheep. Twenty sheep were divided into four groups: the lean and fat groups were given saline, while the lean-R and fat-R groups received RSTN one hour prior to euthanasia. Changes in adiposity influenced the effect of RSTN on LRa mRNA transcript levels in the POA, ARC and AP and without detection of LRa in the VMH/DMH. Overall, both photoperiodic and nutritional signals influence the effects of RSTN on leptin transport to the CNS and are involved in the adaptive/pathological phenomenon of leptin resistance in sheep.

We hypothesized that resistin is engaged in the development of leptin central insensitivity/resistance in sheep, which is a unique animal model to explore reversible leptin resistance. Thirty Polish Longwool ewes, which were ovariectomized with estrogen replacement, were used. Treatments consisted of the intravenous injection of control (saline) or recombinant bovine resistin (rbresistin): control (Control; n = 10), a low dose of rbresistin (R1; 1.0 μg/kg body weight (BW); n = 10), and a high dose of rbresistin (R2; 10.0 μg/kg BW; n = 10). The studies were performed during short-day (SD) and long-day (LD) photoperiods. Leptin and resistin concentrations were determined. Expression levels of a suppressor of cytokine signaling (SOCS)-3 and the long form of the leptin receptor (LeptRb) were determined in selected brain regions, including in the anterior pituitary (AP), hypothalamic arcuate nucleus (ARC), preoptic area (POA), and ventro- and dorsomedial nuclei (VMH/DMH). The results indicate that resistin induced a consistent decrease in LeptRb (except in POA) and an increase in SOCS-3 expression during the LD photoperiod in all selected brain regions. In conclusion, the results demonstrate that the action of resistin appears to be strongly associated with photoperiod-driven changes in the leptin signaling pathway, which may underlie the phenomenon of central leptin resistance.

This study aimed to expand the knowledge of the interactions between prolactin (PRL) and leptin in the ovine mammary gland during pregnancy and lactation; we examined the mRNA expression of prolactin receptor (PRLR), the long form of the leptin receptor (LRb) and suppressor of cytokine signaling (SOCS)-3 in mammary gland biopsies collected on days 60, 90 and 120 of pregnancy and on days 30, 60 and 90 of lactation (n = 6 for each time point), along with the plasma PRL and leptin concentrations. The PRL concentrations were stable throughout pregnancy and increased during lactation. The plasma leptin concentrations were comparable among nonpregnant, early-pregnant, late-pregnant and lactating ewes, but this metric peaked during mid-pregnancy. Expression of and in the mammary gland fluctuated during the transition from pregnancy to lactation, and differences in expression occurred during the late stages of lactation. The transcript abundance was approximately 31 times higher in ewes on day 60 of lactation than in early-lactating ewes. Expression of mRNA in biopsies gradually decreased over the course of pregnancy and reached a minimum value during late pregnancy. After lambing, the transcript level of increased and peaked on day 60 of lactation. During pregnancy, the plasma PRL concentration positively correlated with the abundances of PRLR (r = 0.971, P<0.01) and SOCS-3 (r = 0.818, P<0.05). Positive correlations were also observed between the transcript abundances of SOCS-3 and LRb (r = 0.854, P<0.05). The variations observed in the plasma PRL and leptin concentrations and the changes in expression of key leptin and PRL signal transduction pathway components, such as PRLR, LRb and SOCS-3, indicate that the efficacies of both hormone actions are modulated in a multilevel manner throughout pregnancy and lactation. These interactions may regulate the ability of the mammary gland to respond to current energy requirements and challenges, thus affecting milk yield and lactation duration.

The maintenance of energy homeostasis is achieved with ‘detectors’ that receive signals from the external and internal environment and with multidirectional ‘communication routes’ including neuronal networks and body fluids, such as blood and cerebrospinal fluid. Changes in the energy demands of organisms are caused by current physiological status and environmental conditions, including season and food availability. Little is known about the interactions between the metabolic indicators involved in the maintenance of energy homeostasis, e.g., leptin, orexins and ghrelin. Sheep and other seasonal animals are highly adaptable to their environments because of the plasticity of their neural and endocrine systems. Sheep exhibit leptin resistance and are thus an extremely interesting model for research on the relationship between hormonal indicators of energy metabolism. The paper is focused mainly on the anatomical and functional communication between leptin, ghrelin and orexins, which play principal roles in the adaptation of energetic demands to environmental fluctuations.

The influence of leptin on orexin A and the interaction of leptin with ghrelin in regulating the gonadotropic and somatotropic axes in seasonally polyestrous animals are not well understood. This study examined the effects of these factors as well as the mediating roles of specific ovine leptin antagonist (SOLA; mutant D23L/L39A/D40A/F41A) and photoperiod on luteinizing hormone (LH) and growth hormone (GH) secretion. Twenty-four ovariectomized, estradiol-implanted ewes were used in a replicated switchback design. The ewes were assigned randomly to 1 of 6 treatments (infused into the third ventricle 3 times at 0 (dusk), 1, and 2 h) as follows: control, Ringer-Locke buffer; leptin, 0.5 μg/kg b.w.; orexin A, 0.3 μg/kg b.w.; ghrelin, 2.5 μg/kg b.w.; SOLA, 50 μg/kg b.w. + orexin A, 0.3 μg/kg b.w.; and SOLA, 50 μg/kg b.w. + ghrelin, 2.5 μg/kg b.w. Blood samples (5 ml) were collected at 15-min intervals for 4 h. SOLA + orexin A resulted in an increase (P<0.01) in the LH plasma concentration during short-day (SD) and long-day (LD) photoperiods. However, ghrelin and SOLA + ghrelin had the opposite effect. SOLA + orexin A resulted in an increase (P<0.001) in the GH concentration compared with leptin or orexin A during the LD season. Ghrelin and SOLA + ghrelin increased the GH concentration (P<0.01) regardless of the season. In summary, LH and GH secretion are seasonally dependent on relationships that are subject to photoperiodic regulation, and leptin is an important regulator of the effects of ghrelin and orexin A on the activities of the gonadotropic and somatotropic axes in sheep.

Leptin and resistin play important roles in regulating body weight and glucose metabolism. Herein, we hypothesized that resistin is a factor leading to decreased tissue sensitivity to leptin through effects on SOCS-3 and LeptRb expression. Expression of SOCS-3 and LeptRb were determined using Real-Time PCR in selected brain tissues: arcuate nucleus (ARC), ventro- and dorsomedial nuclei (VMH/DMH), preoptic area (POA) and anterior pituitary (AP). Thirty ewes (10/group), ovariectomized with E2-replacement, were fed ad libitum and housed under natural photoperiod. Intravenous treatments consisted of 1) control, 2) low dose of rbresistin (R1; 1.0 μg/kg BW), and 3) high dose of rbresistin (R2; 10.0 μg/kg BW). During long days (LD), LeptRb transcript in ARC decreased in response to R2 (P < 0.001) compared to Control. Expression of LeptRb in VMH/DMH decreased in response to R1(P < 0.001) and R2 (P < 0.001) during short days (SD) and to R2 (P < 0.001) during LD. Conversely, LeptrB transcript increased (P < 0.001) 8-fold in R1 and 4-fold in R2 (P < 0.05) in POA during SD. LeptrB transcript in the AP increased (P < 0.001) 2.1- and 1.8-fold, respectively, in response to R1 and R2 during LD. Within the ARC, SOCS-3 expression increased (P < 0.001) after R2 in LD. In POA, a 2.3-fold (P < 0.001) increase was noted in R2 only during LD. Moreover, SOCS-3 transcript increased in the AP during both LD (8.5-fold) and SD (5.8-fold) in response to R2 (P < 0.001). Evidence indicates that resistin resulted in a consistent decrease in LeptRb (except POA) and increase in SOCS-3 expression during LD in all hypothalamic nuclei. In AP, resistin increased SOCS-3 during both LD and SD and LeptRb transcript during LD. Taken together, the effects of resistin appear to be strongly associated with photoperiod-driven changes in the leptin signaling pathway, which may underlie the phenomenon of leptin resistance.